Neuland Laboratories fixes July 24 record date for dividend

1 min read     Updated on 17 Jun 2026, 04:37 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Neuland Laboratories Limited has fixed July 24, 2026, as the record date for the final dividend for the financial year ended March 31, 2026, pending approval at the 42nd Annual General Meeting. The AGM is scheduled for August 4, 2026, via Video Conferencing. Shareholders must update bank and email details to receive dividend payments electronically.

powered bylight_fuzz_icon
43128622

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories Limited has fixed July 24, 2026, as the record date to determine the entitlement of members to the final dividend for the financial year ended March 31, 2026. The dividend payment is subject to approval at the company's upcoming 42nd Annual General Meeting. The record date announcement was made in a regulatory filing submitted to the exchanges.

The company announced that its 42nd Annual General Meeting will be held on Tuesday, August 4, 2026, at 10.00 a.m. IST through Video Conferencing and Other Audio Visual Means. This meeting is being conducted in accordance with relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The notice of the AGM and the Integrated Annual Report for the financial year 2025-26 will be sent to members whose email addresses are registered with the company or depository participants.

Shareholders holding shares in physical form have been advised to register or update their bank account mandates and email addresses using the prescribed Form ISR-1 with KFin Technologies Limited, the company's Registrar and Transfer Agent. Physical folios lacking these details will only be eligible for lodging grievances or service requests after the necessary information is registered. Members holding shares in electronic form can update their details through their depository participants.

The company stated that the final dividend will be paid electronically through online transfer modes to shareholders who have updated their bank account details. For those who have not updated their details or are non-compliant with KYC norms, an intimation in lieu of the dividend instrument will be sent to their registered address. Neuland Laboratories also reminded members that dividend income is taxable under the Income Tax Act, 2025, and the company is required to deduct Tax at Source at prescribed rates.

To ensure compliance with Tax at Source requirements, members have been requested to complete or update their residential status, PAN, and category details with their depository or the company. Separate communication regarding the procedure for availing applicable tax rates and exemption forms was sent to members on June 12, 2026, and is available on the company's website.

Key Event Date
Record Date July 24, 2026
42nd AGM August 4, 2026

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-1.43%+0.80%+1.72%+30.31%+704.27%

What dividend payout ratio does Neuland Laboratories aim to maintain for FY2026?

How will the company's capital allocation strategy evolve post-dividend approval?

What impact could the dividend announcement have on Neuland's stock liquidity?

Neuland Laboratories to hold non-deal roadshow on June 11

0 min read     Updated on 06 Jun 2026, 03:08 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Neuland Laboratories announced a non-deal roadshow on June 11, 2026, in Hyderabad, organized by Goldman Sachs. The management will engage with analysts and investors to discuss business outlook and performance. The schedule is subject to change based on exigencies.

powered bylight_fuzz_icon
42180147

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories has announced that its management will engage with analysts and institutional investors through a non-deal roadshow scheduled for June 11, 2026. The meeting, organized by Goldman Sachs, will be held in Hyderabad and will serve as a platform for the company to present its business outlook and operational performance to potential investors.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sarada Bhamidipati, Company Secretary of Neuland Laboratories Limited, confirmed the schedule in the filing submitted on June 5, 2026.

The event will feature both group meetings and one-on-one interactions, allowing for detailed discussions regarding the company's financial health and strategic initiatives. The schedule and participant list remain subject to change based on exigencies from either the participants or the company.

Meeting Schedule

Date Name of the Analyst / Institutional Investor / Event Location Nature of the meeting
June 11, 2026 Goldman Sachs Non-deal roadshow (NDR) Hyderabad Group meet / One-on-One meet

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-1.43%+0.80%+1.72%+30.31%+704.27%

What strategic initiatives is Neuland Laboratories likely to highlight during the roadshow to attract institutional investors?

How might the outcome of this non-deal roadshow influence Neuland Laboratories' stock performance in the short term?

What are the potential market reactions if the company announces significant operational updates or financial targets during the meeting?

More News on Neuland Laboratories

1 Year Returns:+30.31%